BSE · UNJHAFOR
Unjha Formulations Ltd.
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,261
of 5,004 stocks
🏆 New peak
▲ 201W
Peak #4,261 · 01 Oct 2026
A microcap name in Healthcare, Unjha Formulations Ltd. is growing revenue at a solid clip, trades at a moderate earnings multiple, and earns a healthy return on equity.
Market Cap
14.56 Cr
P/E Ratio
20.70
P/B Ratio
3.79
ROE
18.34%
ROCE
18.66%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 3.31 Cr | 3.28 Cr | 4.41 Cr | 4.29 Cr |
| Net Profit | 15.69 L | -74.28 L | 23.97 L | 81.78 L |
| EPS | 0.35 | 1.66 | 0.53 | 1.83 |
| Operating Profit | 15.80 L | -49.08 L | 24.14 L | 81.92 L |
Shareholding pattern
Promoter
36.92%
Public
63.08%
PUBLIC BREAKDOWN
Individuals
55.91%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 30 Oct 2023 | Other | E.G.M. |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.